Esophagitis: clinical and endoscopic assessment of sucralfate therapy.

Simple item page
dc.contributor.authorChopra, B Ken_US
dc.contributor.authorKazal, H Len_US
dc.contributor.authorMittal, P Ken_US
dc.contributor.authorSibia, S Sen_US
dc.date.accessioned1991-03-01en_US
dc.date.accessioned2009-05-29T05:42:41Z
dc.date.available1991-03-01en_US
dc.date.available2009-05-29T05:42:41Z
dc.date.issued1991-03-01en_US
dc.description.abstractTwenty patients with endoscopically proved reflux esophagitis were studied. Each patient was given 1 gm sucralfate 4 times a day for 6 weeks. Clinical and endoscopic assessment of the effects of sucralfate on reflux esophagitis was done. 50% patients became asymptomatic and 60% healed endoscopically. The drug was well tolerated. We conclude that sucralfate is an effective and well tolerated drug for treatment of reflux esophagitis.en_US
dc.description.affiliationDepartment of Medicine Government Medical College/Rajendra Hospital, Patiala.en_US
dc.identifier.citationChopra BK, Kazal HL, Mittal PK, Sibia SS. Esophagitis: clinical and endoscopic assessment of sucralfate therapy. Indian Journal of Medical Sciences. 1991 Mar; 45(3): 55-7en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/67967
dc.language.isoengen_US
dc.source.urihttps://www.indianjmedsci.orgen_US
dc.subject.meshAdulten_US
dc.subject.meshEsophagitis, Peptic --diagnosisen_US
dc.subject.meshEsophagoscopyen_US
dc.subject.meshHumansen_US
dc.subject.meshSucralfate --adverse effectsen_US
dc.titleEsophagitis: clinical and endoscopic assessment of sucralfate therapy.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Medical Sciences